Normalizing the Immune Macroenvironment via Debulking Surgery to Strengthen Tumor Nanovaccine Efficacy and Eliminate Metastasis.
暂无分享,去创建一个
Xiaotu Ma | Xiao Zhao | Guangjun Nie | Yale Yue | Guangna Liu | Xin Guo | Keman Cheng | Yao Li | Jie Liang | Nana Ma | Fei Zhu | Tianjiao Zhang | Zhiqiang Chen | Xinwei Wang | Qingqing Feng | Xiaoyu Gao
[1] A. Kennedy,et al. Differences in CD80 and CD86 transendocytosis reveal CD86 as a key target for CTLA-4 immune regulation , 2022, Nature Immunology.
[2] Peiwen J. Ma,et al. Nanoparticle-based medicines in clinical cancer therapy , 2022, Nano Today.
[3] Xiao Zhao,et al. Nanocarriers based on bacterial membrane materials for cancer vaccine delivery , 2022, Nature Protocols.
[4] Xiao Zhao,et al. Nanotechnology-empowered vaccine delivery for enhancing CD8+ T cells-mediated cellular immunity. , 2021, Advanced drug delivery reviews.
[5] Yiye Li,et al. Multifunctional biomolecule nanostructures for cancer therapy , 2021, Nature Reviews Materials.
[6] Jie Liang,et al. Bioengineered bacteria-derived outer membrane vesicles as a versatile antigen display platform for tumor vaccination via Plug-and-Display technology , 2021, Nature Communications.
[7] Yuliang Zhao,et al. Development of a Cancer Vaccine Using In Vivo Click‐Chemistry‐Mediated Active Lymph Node Accumulation for Improved Immunotherapy , 2021, Advanced materials.
[8] E. Beswick,et al. G-CSF in tumors: Aggressiveness, tumor microenvironment and immune cell regulation. , 2021, Cytokine.
[9] D. Gabrilovich,et al. Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity , 2021, Nature Reviews Immunology.
[10] P. Ott,et al. Advances in the development of personalized neoantigen-based therapeutic cancer vaccines , 2021, Nature Reviews Clinical Oncology.
[11] Yi Zhang,et al. M2 macrophage‐derived G‐CSF promotes trophoblasts EMT, invasion and migration via activating PI3K/Akt/Erk1/2 pathway to mediate normal pregnancy , 2021, Journal of cellular and molecular medicine.
[12] Ting Zhang,et al. Tumor-Associated Macrophages in Tumor Immunity , 2020, Frontiers in Immunology.
[13] Kai Yang,et al. A general strategy towards personalized nanovaccines based on fluoropolymers for post-surgical cancer immunotherapy , 2020, Nature Nanotechnology.
[14] J. Moon,et al. Engineered Nanoparticles for Cancer Vaccination and Immunotherapy. , 2020, Accounts of chemical research.
[15] Baoquan Ding,et al. A DNA nanodevice-based vaccine for cancer immunotherapy , 2020, Nature Materials.
[16] Limin Zheng,et al. Generation of Myeloid Cells in Cancer: The Spleen Matters , 2020, Frontiers in Immunology.
[17] Kamir J. Hiam,et al. Systemic dysfunction and plasticity of the immune macroenvironment in cancer models , 2020, Nature Medicine.
[18] Shuang Wang,et al. Self-healing microcapsules synergetically modulate immunization microenvironments for potent cancer vaccination , 2020, Science Advances.
[19] Taoyong Chen,et al. Publisher Correction: K33-linked polyubiquitination of Zap70 by Nrdp1 controls CD8+ T cell activation , 2020, Nature Immunology.
[20] M. Howarth,et al. Approaching infinite affinity through engineering of peptide–protein interaction , 2019, Proceedings of the National Academy of Sciences.
[21] Aaron T. L. Lun,et al. Transcription Factor PU.1 Promotes Conventional Dendritic Cell Identity and Function via Induction of Transcriptional Regulator DC‐SCRIPT , 2019, Immunity.
[22] Xianghua Wu,et al. Therapeutic cancer vaccines: From initial findings to prospects. , 2018, Immunology letters.
[23] R. Aft,et al. Breast and pancreatic cancer interrupt IRF8-dependent dendritic cell development to overcome immune surveillance , 2018, Nature Communications.
[24] J. Hamilton,et al. Neutrophils, G‐CSF and their contribution to breast cancer metastasis , 2018, The FEBS journal.
[25] L. Joosten,et al. Modulation of Myelopoiesis Progenitors Is an Integral Component of Trained Immunity , 2018, Cell.
[26] D. Gabrilovich,et al. Myeloid-derived suppressor cells coming of age , 2018, Nature Immunology.
[27] R. Tampé,et al. Structure of the human MHC-I peptide-loading complex , 2017, Nature.
[28] Nicholas A. Sinnott-Armstrong,et al. An improved ATAC-seq protocol reduces background and enables interrogation of frozen tissues , 2017, Nature Methods.
[29] Wensheng Zhang,et al. Genome‐wide analysis of DNA methylation profiles in a senescence‐accelerated mouse prone 8 brain using whole‐genome bisulfite sequencing , 2017, Bioinform..
[30] J. Moon,et al. Designer vaccine nanodiscs for personalized cancer immunotherapy , 2016, Nature materials.
[31] V. Beneš,et al. Epigenetic program and transcription factor circuitry of dendritic cell development , 2015, Nucleic acids research.
[32] Berthold Göttgens,et al. Functionally Distinct Subsets of Lineage-Biased Multipotent Progenitors Control Blood Production in Normal and Regenerative Conditions. , 2015, Cell stem cell.
[33] W. Huber,et al. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2 , 2014, Genome Biology.
[34] R. Xavier,et al. Epigenetic programming of monocyte-to-macrophage differentiation and trained innate immunity , 2014, Science.
[35] R. Consolini,et al. Numerical defect of circulating dendritic cell subsets and defective dendritic cell generation from monocytes of patients with advanced melanoma. , 2013, Cancer letters.
[36] Lieping Chen,et al. Molecular mechanisms of T cell co-stimulation and co-inhibition , 2013, Nature Reviews Immunology.
[37] Percy A. Knolle,et al. Antigen-presenting cell function in the tolerogenic liver environment , 2010, Nature Reviews Immunology.
[38] M. Patarroyo,et al. Comparison of the adjuvanticity of two different delivery systems on the induction of humoral and cellular responses to synthetic peptides , 2010, Drug delivery.
[39] C. Glass,et al. Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities. , 2010, Molecular cell.
[40] J. Bähler,et al. Cellular and Molecular Life Sciences REVIEW RNA-seq: from technology to biology , 2022 .
[41] M. Nussenzweig,et al. A role for lipid bodies in the cross-presentation of phagocytosed antigens by MHC class I in dendritic cells. , 2009, Immunity.
[42] Clifford A. Meyer,et al. Model-based Analysis of ChIP-Seq (MACS) , 2008, Genome Biology.
[43] H. Spits,et al. The transcription factor Spi-B is expressed in plasmacytoid DC precursors and inhibits T-, B-, and NK-cell development. , 2003, Blood.
[44] Tom H. Pringle,et al. The human genome browser at UCSC. , 2002, Genome research.
[45] Hans-Georg Rammensee,et al. A role for the proteasome regulator PA28α in antigen presentation , 1996, Nature.